• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov15
Allarity Therapeutics released FY2025 9 Months Earnings on November 14 (EST), actual revenue USD 0, actual EPS USD -0.5847
04:00
Allarity Therapeutics released FY2025 Q3 earnings on November 14 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.1903 (forecast USD -0.23)
04:00
Nov14
Allarity Therapeutics Publishes Q3 2025 Earnings Report
14:06
Aug27
Allarity Therapeutics Receives FDA Fast Track Designation for Ovarian Cancer Drug
12:01
Aug16
Allarity Therapeutics released FY2025 Semi-Annual Earnings on August 15 (EST) with actual revenue of USD 0 and EPS of USD -0.3782
03:00
Allarity Therapeutics released FY2025 Q2 earnings on August 15 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.1499 (forecast USD -0.21)
03:00

Schedules & Filings

Schedules
Filings
Nov14
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -2.806 M, EPS -0.1903

Aug15
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -2.32 M, EPS -0.1492

May9
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -2.732 M, EPS -0.245

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
AMCI
11.670
+84.65%
+5.376
SOBR
2.349
+80.71%
+1.041
OMER
14.521
+65.96%
+5.790
MWG
0.4000
+58.04%
+0.146
EUDA
2.720
+41.67%
+0.800
DVAX
15.430
+38.63%
+4.300
INDP
2.660
+36.41%
+0.682
AFJK
56.444
+28.25%
+12.434
IZM
2.297
+27.59%
+0.497
TSE
0.6048
+27.09%
+0.127
View More